↓ Skip to main content

Vitex agnus castus for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review

Overview of attention for article published in Archives of Women's Mental Health, October 2017
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
3 news outlets
twitter
16 X users
facebook
4 Facebook pages
wikipedia
3 Wikipedia pages
video
1 YouTube creator

Citations

dimensions_citation
39 Dimensions

Readers on

mendeley
181 Mendeley
Title
Vitex agnus castus for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review
Published in
Archives of Women's Mental Health, October 2017
DOI 10.1007/s00737-017-0791-0
Pubmed ID
Authors

Raphael O. Cerqueira, Benicio N. Frey, Emilie Leclerc, Elisa Brietzke

Abstract

The objective of this study was to evaluate whether Vitex agnus castus is a safe and effective treatment for PMS and premenstrual dysphoric disorder (PMDD) and to discuss the implications of these findings for clinical practice. A systematic review of literature was conducted using PubMed and Scielo databases. The inclusion criteria were randomized controlled trials (RCT) using V. agnus castus in individuals with PMS or PMDD that compared this intervention with placebo or an active comparator and included a description of blinding and dropouts/withdrawals. The search was conducted by two independent investigators who reached consensus on the included trials. A total of eight RCTs were included in this study. Most studies focused on PMS, and the diagnostic criteria of PMS and PMDD changed over the years. Three different preparations of V. agnus castus (VAC) were tested, and there was significant variability in the measurement of treatment outcomes between the studies. Nevertheless, all eight studies were positive for VAC in the treatment of PMS or PMDD and VAC was overall well tolerated. Main limitations were differences in definition of diagnostic criteria, the instruments used as main outcome measures, and different preparations of VAC extracts limit the comparison of results between studies. In conclusion, the RCTs using VAC for treatment of PMS/PMDD suggested that the VAC extract is a safe and efficacious alternative to be considered for the treatment of PMS/PMDD symptoms.

X Demographics

X Demographics

The data shown below were collected from the profiles of 16 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 181 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 181 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 35 19%
Student > Master 18 10%
Student > Doctoral Student 17 9%
Researcher 14 8%
Other 13 7%
Other 29 16%
Unknown 55 30%
Readers by discipline Count As %
Medicine and Dentistry 45 25%
Nursing and Health Professions 19 10%
Biochemistry, Genetics and Molecular Biology 12 7%
Pharmacology, Toxicology and Pharmaceutical Science 10 6%
Agricultural and Biological Sciences 9 5%
Other 27 15%
Unknown 59 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 44. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 August 2023.
All research outputs
#935,590
of 25,321,938 outputs
Outputs from Archives of Women's Mental Health
#53
of 1,017 outputs
Outputs of similar age
#19,359
of 335,100 outputs
Outputs of similar age from Archives of Women's Mental Health
#3
of 26 outputs
Altmetric has tracked 25,321,938 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,017 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.9. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 335,100 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.